Ubs Group Ag Happiness Development Group LTD Transaction History

Ubs Group Ag

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.16 - $0.29 $3,156 - $5,721	-19,728 Reduced 95.48%	935 $0
Q2 2022 Aug 10, 2022	BUY	$0.17 - $0.35 $3,512 - $7,232	20,663 New	20,663 $4,000
Q1 2022 May 16, 2022	SELL	$0.26 - $0.58 $7,661 - $17,092	-29,469 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.5 - $0.98 $12,863 - $25,211	25,726 Added 687.31%	29,469 $17,000
Q3 2021 Nov 15, 2021	BUY	$0.92 - $1.6 $3,036 - $5,280	3,300 Added 744.92%	3,743 $4,000
Q2 2021 Aug 13, 2021	BUY	$1.52 - $2.08 $673 - $921	443 New	443 $1,000
Q1 2021 May 12, 2021	SELL	$1.69 - $2.57 $5,960 - $9,064	-3,527 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$1.68 - $1.98 $5,925 - $6,983	3,527 New	3,527 $6,000
Q3 2020 Nov 12, 2020	SELL	$1.75 - $2.87 $18,560 - $30,439	-10,606 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$2.58 - $3.39 $27,363 - $35,954	10,606 New	10,606 $30,000
Q1 2020 May 01, 2020	SELL	$2.52 - $5.16 $6,783 - $13,890	-2,692 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.18 - $5.19 $11,252 - $13,971	2,692 New	2,692 $12,000

Ticker HAPP
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 3,342,730
Market Cap $11.6M
Description
Happiness Development Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chin...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.